Picture of Consun Pharmaceutical logo

1681 — Consun Pharmaceutical News Story

0.000.00%
hk flag iconLast trade - 00:00
HealthcareBalancedMid CapSuper Stock

Brief: Consun Pharmaceutical Group FY ‍Profit Attributable RMB396.2 Mln

March 21 (Reuters) - Consun Pharmaceutical Group Ltd
 1681.HK :
    * ‍PROFIT FOR YEAR ENDED 31 DECEMBER 2017 ATTRIBUTABLE
RMB396.2
MILLION, AN INCREASE OF 28.8%​
    * ‍PROPOSED TO DECLARE A FINAL DIVIDEND OF HKD0.10 PER
SHARE​
    * FY REVENUE RMB1.66 BILLION VERSUS RMB1.22 BILLION

Source text for Eikon:  urn:newsml:reuters.com:*:nHKSbR5clZ
Further company coverage:  1681.HK 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Consun Pharmaceutical

See all news